TrialThe Journal of antimicrobial chemotherapy2023

Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial.

Peter G Pappas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.